S&P 500 7,758 +3.58% Nasdaq 26,691 +5.19% Dow Jones 54,037 +2.96% FTSE 100 10,901 +0.30% DAX 26,319 +2.69% Nikkei 225 65,607 +2.90% Hang Seng 25,668 -0.84% WTI Crude 78.18 -2.69% Gold 4,400 +9.07% US 10-Year Treasury Yield 4.66 -0.55% S&P 500 7,758 +3.58% Nasdaq 26,691 +5.19% Dow Jones 54,037 +2.96% FTSE 100 10,901 +0.30% DAX 26,319 +2.69% Nikkei 225 65,607 +2.90% Hang Seng 25,668 -0.84% WTI Crude 78.18 -2.69% Gold 4,400 +9.07% US 10-Year Treasury Yield 4.66 -0.55%

LATEST

Walmart, Costco, and CVS have a new way to bring you back●Here’s why Wendy’s is losing the burger wars●How a Teenager Is Fighting the World's Crypto Crime Empire●McDonald's says it alienated its most loyal customers●Key HIV stat over 70% leaves BofA siding with Gilead●Can Harvey Nichols find its way back to being Absolutely Fabulous again?●How Scott Bessent used financial engineering to fund the $2 trillion deficit while leaving it untouched●Blackstone's AGS Health files updated draft papers for $500 million India IPO●Walmart, Costco, and CVS have a new way to bring you back●Here’s why Wendy’s is losing the burger wars●How a Teenager Is Fighting the World's Crypto Crime Empire●McDonald's says it alienated its most loyal customers●Key HIV stat over 70% leaves BofA siding with Gilead●Can Harvey Nichols find its way back to being Absolutely Fabulous again?●How Scott Bessent used financial engineering to fund the $2 trillion deficit while leaving it untouched●Blackstone's AGS Health files updated draft papers for $500 million India IPO●

Asia

Global pharma giants turn to Chinese biotech to tap innovation, valuation growth

Business - South China Morning Post · 1h ago · 🇨🇳 China

Global pharma giants turn to Chinese biotech to tap innovation, valuation growth

Global pharmaceutical giants are doubling down on investing in China’s fast-growing biotech companies given the sector’s huge room for valuation growth, according to speakers at the Global Health Summit, which concluded in Hong Kong on Saturday. “Multinational pharmaceutical companies are shifting their business strategies in China away from asset-heavy operations,” said Xu Chenming, head of the healthcare group at Hong Kong-based Citic Securities. “They are moving towards investing in companies...

Read the full story at Business - South China Morning Post →

More Asia

Blackstone's AGS Health files updated draft papers for $500 million India IPO

Markets-Economic Times · 1h ago

Sumadhura Group to invest Rs 2,000 cr on construction of housing project in Bengaluru

Markets-Economic Times · 1h ago

Gold price jumps as reopening of Strait of Hormuz buzz dents US Fed rate-hike hopes. Is it the right time to buy gold?

mint - markets · 1h ago

Explained: How BSE traded fewer contracts after CAS but premiums rose 75% in first week

Markets-Economic Times · 2h ago